SECURITY · REGULATORY TRACEABILITY
The full traceability of our reasoning becomes a compliance instrument before sector supervisory authorities, the EU AI Act, internal controls and adversarial challenges. A legally enforceable contractual commitment.
WHY REGULATORY AUDITABILITY IS STRUCTURING
The Explainable AI page documented our traceability as a technical capability: every insight traces back to the interviews that produced it, every projection stays grounded in its reasoning. This page addresses the same traceability from a complementary angle, the regulatory compliance it makes possible: a compliance team can audit our deliverables before its supervisory authorities, a regulator can exercise its control over the uses made by the players it supervises, an internal ethics committee can validate a consequential deployment, an independent challenger can contest our conclusions line by line.
Without this instrumentation, technical traceability remains under-used: clients hold a capability they do not know how to mobilize against their compliance constraints. Organizing it into audit, control and challenge mechanisms is what turns a product property into a commercial instrument for regulated sectors.
THREE COMPLEMENTARY LEVELS OF AUDITABILITY
An audit firm designated by our client, a sector consultancy, an academic counter-expert or a specialist in auditing AI systems, can fully audit the deliverables we produce: the individual interviews of the synthetic populations, the reasoning paths behind each insight, the statistical calibration protocols, the variance measurements. The audit can be conducted at any point in the lifecycle: before the decision, during deployment, after implementation.
The supervisory authorities our clients answer to, notably the ACPR for banking and insurance, the AMF for financial markets, the HAS for healthcare, the CNIL for personal data, can exercise their control over the uses made of our system by the players they supervise. We contractually commit to making the necessary technical elements available, under the usual confidentiality conditions.
In public decisions or those with strong territorial impact, challenge by third parties, associations, unions, counter-experts, journalists, is a structural feature of democratic debate. Our traceability turns it from a risk to absorb into a dialogue to conduct: a challenger can read our reasoning, point out its limits, propose alternative readings. This dialogue does not weaken our analyses, it demonstrates their seriousness.
THE APPLICABLE REGULATORY FRAMEWORKS
The European regulation on artificial intelligence, in force since 2024-2025, imposes specific traceability, technical documentation and auditability obligations for AI systems classified as high-risk: biometric systems, social scoring systems, systems used in critical infrastructure, systems used in decision processes engaging fundamental rights. Our positioning on these obligations is detailed on the Ethical governance page. Our technical traceability forms the foundation that makes possible the technical documentation the AI Act requires for uses qualifiable as high-risk: without that qualification systematically applying to our deliverables, which most often fall into less strictly regulated categories.
Each sector supervisory authority has its own frameworks applicable to the analysis and decision-support systems used by the players it supervises. The ACPR governs the use of decision-support systems by banks and insurers. The AMF governs the use of quantitative models by financial market players. The HAS governs the use of medical decision-support systems. The CNIL governs all processing of personal data. Our clients in these sectors can request from us the technical documentation needed for their own compliance work before their respective supervisory authorities.
Beyond external regulatory obligations, large companies have internal control bodies: internal ethics committees, compliance departments, internal control departments, internal audit departments. These internal bodies structurally require complete auditability of the analysis and decision-support tools they deploy. Our technical traceability meets these internal requirements without any ad hoc procedure: a large group's internal ethics committee can validate a deployment of our tools on the basis of the same technical documentation that satisfies an external regulatory control.
FRAUD PREVENTION
FRAUD PREVENTION
This case illustrates how structuring regulatory traceability can be in making a consequential deployment possible. A European health insurer was preparing the deployment of a predictive AI to identify at-risk fraud profiles on claims. The ethical and reputational stakes were high: a poorly calibrated system could structurally discriminate against vulnerable policyholder typologies. Our technical traceability allowed the insurer's ethics committee to audit every tested scenario, the legal teams to document compliance with the requirements of the CNIL and the ACPR, and an independent external audit firm commissioned by the ethics committee to validate the methodological robustness of the final system. Without this complete regulatory traceability, the deployment could not have been validated: the stake was not predictive performance but the demonstration of compliance before three independent levels of audit.
Read the full case →THE USES REGULATORY TRACEABILITY OPENS
The regulatory instrumentation of our technical traceability opens uses that players without equivalent instrumentation cannot serve. Our cases illustrate this value across four registers of the regulated sectors.
Banks, insurers, asset managers, payment platforms: compliance teams face growing methodological traceability requirements, from the ACPR and the AMF to their international counterparts. Our traceability lets them precisely document the methodology of the systems they deploy: scoring, fraud detection, credit decision support, customer segmentation.
Public and private healthcare providers, pharmaceutical companies, mutual and health insurers, health authorities: healthcare players answer to specific requirements, from the HAS and the ANSM to their international counterparts. Our traceability enables the methodological validation of sensitive subjects: public health policies, prevention campaigns, evaluation of medical devices, impact of therapeutic policies.
Ministries, independent authorities, public operators, local governments: public players answer to parliamentary controls, administrative courts and independent oversight bodies. A minister defending a policy informed by our work holds methodological documentation auditable line by line by the parliamentary representation or an independent rapporteur.
Organizations deploying AI systems classified as high-risk under the AI Act face specific technical documentation, traceability and auditability obligations. Our regulatory traceability forms the documentary foundation that satisfies these requirements, with no ad hoc procedure and no methodological overhead.
Sector compliance teams, internal ethics committees, legal departments, internal audit departments: our team can provide you with the detailed documentation of our regulatory traceability, the independent external audit protocols we accept, the standard contractual clauses on making technical elements available to supervisory authorities, and the ways we demonstrate compliance with the EU AI Act. Regulatory traceability is a legally enforceable contractual commitment: not a sales argument.
See ethical governance →